Evidence summary
Historical records cover approximately 25 patients. Available documentation describes local tissue changes and both local and serious adverse events.
Where the historical records came from
The brochure summarizes records from approximately 25 patients. Most were treated in Germany, with other records from China, Mexico and Italy. The material comes from prior physician-led care and includes symptoms, photographs, imaging and some pathology findings.
Lesion changes, symptoms and pathology
In one case of an ulcerated breast tumor with bleeding, the record describes cessation of bleeding, pain relief and necrosis in most of the tumor. In a different breast cancer case, surgical pathology found no malignancy in the treated specimen while a deeper, uninjected mass remained viable. The pathology finding therefore refers to the sampled treatment zone.
Imaging and follow-up records
The brochure describes a metastatic squamous cell carcinoma lymph node in the neck that developed necrosis and later showed avascular fibrosis. In a case of recurrent breast cancer, two lesions showed necrosis and healing. The record describes local control lasting more than 14 months for the lesions in that case.
Adverse events recorded in the historical material
The brochure records injection-site pain, transient fever and drainage or expulsion of dead tissue. The records also include a superficial chemical burn associated with needle-track reflux, suppurative inflammation in a treated zone, and one episode of serious infection and sepsis after suspected perforation of a necrotic bowel tumor.
